BUSINESS● LOWSep 16 · Sep 16, 2026, 12:36 PM
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
biospace · united states of america · global
Xenetic Biosciences and Santersus AG have announced a definitive share exchange agreement to form a global leader in NET-targeting therapeutics. This agreement aims to consolidate their positions in the specialized medical treatment market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapunited states of america and nearby eventsMore from united states of americaLatest stories and threat level
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoThe world’s biggest fine jewellery factory: How Pandora aims to make more and pollute less in VietnamEuroNews [en]BUSINESS43m agoHong Kong’s new Huanggang Port seemingly quiet ahead of expected holiday rushSouth China Morning Post